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Abstract
Modified carboxymethyl chitosan (CMC) containing phosphatidylethanolamine (PEA) groups were synthesized by a 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)-mediated coupling reaction. The structure of the modified CMC
exhibiting an amphiphilic character was analysed by FT-IR and 1H NMR. CMC-g-PEA beads were prepared with sodium
tripolyphosphate (TPP) by ionic-crosslinking. The beads sizes were in range from 800 to 1200 lm and encapsulation effi-
ciencies of drug were more than 68%. The morphologies of CMC-g-PEA beads were examined with scanning electron
microscopy (SEM). The release experiments were performed using ketoprofen as an hydrophobic model drug. The drug
dissolution kinetics showed longer release times for CMC-g-PEA beads: 20 h (at pH 1.4) and 45 h (at pH 7.4). The amount
of the drug release was much higher in acidic solution than in basic solution due to the swelling properties of the matrix at
acidic pH. These results suggest that modified CMC with PEA may become a potential delivery system to control the
release of hydrophobic drugs.
! 2006 Elsevier B.V. All rights reserved.
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1. Introduction
Interest in polymeric matrices for pharmaceutical
formulation continues to grow specially those that
react to external stimuli (e.g. pH or temperature),
allowing to target the release of drugs in specific
conditions or site. Special attention is currently
given to chitosan, a poly(aminosaccharide), nor-
mally obtained by partial alkaline deacetylation of
chitin, the principle component of living organisms
such as fungi and crustacean. This naturally occur-
ring polymer has a repeating structural unit of 2-
acetamido-2-deoxy-b-D-glucose [1,2]. Since chitosan
itself is non-toxic [3], biodegradable [4] and biocom-
patible [5], several biological applications have been
reported for chitosan, including chelation processes
[6], a cholesterol trap [7] and a drug carrier [8,9].
However, chitosan is only soluble in a few dilute
acid solutions, which limits its wide applications.
Recently, there has been a growing interest in chem-
ical modification of chitosan to improve its solubil-
ity and widen its applications [10,11]. The chemical
1381-5148/$ - see front matter ! 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.reactfunctpolym.2006.09.001
* Corresponding author. Tel.: +351 253510330; fax: +351
253510339.
E-mail address: jmano@dep.uminho.pt (J.F. Mano).
Reactive & Functional Polymers 67 (2007) 43–52
www.elsevier.com/locate/react
REACTIVE&FUNCTIONALPOLYMERS
modification is a powerful tool to control the inter-
action of the polymer with drugs, to enhance the
drug loading efficiency as well as tailor the drug
release period. Chemically modified chitosans have
great utility in controlled release and targeting stud-
ies of almost all class of bioactive molecules. There-
fore, the interest in chitosan and its derivatives as
excipients in drug delivery has been increased in
recent years. Chitosan has been modified by ionic-
crosslinking (e.g. with tripolyphosphate, TPP) to
prepare intelligent drug delivery systems [12], and
by carboxymethylation for repair and regeneration
of bone tissues [13] or use as antioxidant agent
[14]. Chitosan has also been conjugated with a-
galactosyl for use as an inhibitor in acute rejection
following xenotransplantation [15], with vinylsulfo-
nate as an antimicrobial agent [16], and with sulfate
as an activator of blood anticoagulant factors [17].
Self-assembled nano/microparticles, composed
of polymeric amphiphiles, have been considered to
provide opportunities for the site-specific delivery
of drugs because they can solubilize various hydro-
phobic drugs, increase bioavailability, and stay
unrecognized during blood circulation [18,19]. In
this context, chitosan was acylated with fatty acyl
chlorides to introduce hydrophobicity for use as a
matrix for drug delivery and glycol chitosan was
hydrophobically modified with deoxycholic acid,
5b-cholanic acid and doxorubicin to yield self-
aggregates as potential drug carriers [20–23]. Glycol
chitosan was also modified with palmitoyl N-
hydroxysuccinimide to form vesicles [24] and hydro-
gels [25]. These derivatives present amphiphilic
characteristics, stabilized by hydrophobic interac-
tions, and exhibit erosion-controlled drug release
for 5–7 h. Recently, we have synthesized a pH-
responsive chitosan derivative bearing b-cyclodex-
trin cavities to be used as a matrix for controlled
drug release [26]. Due to the presence of hydropho-
bic b-cyclodextrin rings, this system provided a
slower release of the entrapped hydrophobic drug.
In the present study, water soluble carboxymethyl
chitosan (CMC) was prepared from chitosan and
hydrophobically modified by covalent attachment
of phosphatidylethanolamine (PEA) to CMC
through amide bond formation. This system may
form polymeric micelles composed by hydrophobic
PEA segments as the internal core and hydrophilic
CMC segments as a surrounding corona in an aque-
ous solution. It was expected that such derivatiza-
tion would reduce hydration of the matrix and
play a role in network stabilization by hydrophobic
interactions. For the drug delivery study, CMC-g-
PEA beads were prepared based on ionic gelation
method by using sodium tripolyphosphate (TPP)
as an ionic-crosslinking agent [27]. The feasibility
of these beads as a delivery carrier for the transfec-
tion of hydrophobic model drug, ketoprofen was
investigated. The morphological observations and
swelling properties of beads were evaluated. We
believe that the main conclusions that may be
obtained using beads could be extended to other
geometrical models, such as nano/microparticles,
bulk hydrogels or porous three-dimensional con-
structs in order to be used in tissue engineering
applications.
2. Materials and method
2.1. Materials
Chitosan (viscosity average molecular weight
6.7 · 105 g/mol, degree of N-deacetylation 75–85%)
was purchased from Sigma Chemical Company.
Before used, it was purified by the method of dis-
solving in acetic acid and separating with alkali.
PEA and EDC were from Sigma–Aldrich and used
without further purification. Chloroacetic acid, TPP
and sodium hydroxide were supplied by Fluka
Chemical Company and used as supplied. All other
chemicals used were of analytical reagent grade.
2.2. Preparation of CMC
CMC was prepared according to a method
described by Chen et al. [28]. Purified chitosan
(8.0 g) was added into 40 g of 50 wt% NaOH solu-
tion and put into a refrigerator at !18 "C overnight
for alkylization. After the excessive alkali solution
was extruded, chitosan was put into a 250 ml reac-
tor containing 40 ml of isopropyl alcohol. Then,
10 g of chloroacetic acid dissolved in 40 ml of iso-
propyl alcohol was added into the reactor drop
wise. Afterwards, this reaction mixture was refluxed
at 65 "C under extensive stirring. After an addi-
tional 2 h the reaction was stopped and the solvent
was discarded. The mixture was neutralized with
hydrochloric acid and then precipitated in acetone.
The product was carefully washed successively by
acetone, absolute alcohol and 75% (v/v) alcohol
and then dried at 60 "C under vacuum. The elemen-
tal analysis showed that the substitution degree of
carboxymethylation of CMC is 0.65. Analytical
and calculated data for [C6H8O4(NH2)0.85(NHC-
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OCH3)0.15(C2H3O2)0.65(H)0.35 Æ 1.6H2O]n was deter-
mined as C 39.10, N 6.04, H 6.72 and C 39.04, N
5.99, H 6.67, respectively.
2.3. Preparation of CMC-g-PEA
PEA (300 mg) in the mixture of toluene and
methanol (5:1 ratio) was added to a 1 wt% carb-
oxymethyl chitosan solution followed by the drop
wise addition of EDC (0.71 g) under constant stir-
ring at room temperature. After 15 hours, the reac-
tion mixture was poured into the acetone. The
precipitates were filtered off, washed thoroughly
with methanol and acetone, and then followed by
vacuum drying at room temperature. Elemental
analysis showed a significant reduction of N con-
tent when comparing the obtained product
(3.71%) with pure CMC (6.04%). The N content
of the product corresponds to a degree of substitu-
tion 62%, showing that most of the carboxyl
groups in CMC were grafted with amine groups
of PEA. The degree of substitution was calculated
from the N content of the product with the follow-
ing equation:
½14! ð217$N%Þ&=½ð635$N%Þ ! 14&
where 217 is the weight of one gluco-pyranoside
moiety of CMC molecule after deducting OH! from
carboxymethyl group, 14 is the weight of N in the
CMC and PEA, and 635 is the molecular weight
of PEA after deducting H atom.
2.4. Characterization
The IR spectra of CMC and its derivatives were
recorded with a double-beam Perkin–Elmer 1600
FT-IR spectrometer in the range of 4000–
400 cm!1 using KBr pellets. 1H NMR spectrum
of the samples was recorded on a Varian Unity
Plus 300 MHz spectrometer in D2O at 25 "C. The
samples were dissolved in a 5 mm diameter tube
at a concentration of 20 mg/ml. For the control
PEA, CDCl3 was used as a solvent. The elemental
analyses were carried out with a Leco CHNS 932
instrument. The morphology of CMC-g-PEA
beads was analysed using a Leica Cambridge
S360 SEM at an accelerating voltage of 15 kV.
Absorbance measurements were carried out in a
Shimadzu UV–visible spectrophotometer model
UV-1601. A calibration curve of absorbance
against different concentrations of ketoprofen was
made at 267 nm.
2.5. Preparation of drug loaded crosslinked CMC-g-
PEA beads
CMC-g-PEA solution was prepared by dissolv-
ing 1.0 g of CMC-g-PEA in 100 ml of distilled
water. With this solution, a known amount of keto-
profen (0.5 and 1 g) in 5 ml of ethanol was added
and dispersed under constant stirring. This mixture
was dropped through a syringe into 100 ml of 10%
(w/v) TPP aqueous solution and the gelled spheres
formed instantaneously. During this process, pH
of the TPP solution was maintained at 4.0 by using
dilute HCl. The formed CMC-g-PEA beads
remained in this solution for 1 h and were then
washed with deionized water repeatedly, and finally
dried at room temperature. A similar method is fol-
lowed for the preparation of control chitosan beads
loaded with drug.
2.6. Determination of initial drug content
A weighed quantity (50 mg) of drug loaded beads
was extracted with ethanol at 37 "C for 48 h under
uniform stirring. After centrifugation, the ketopro-
fen in the supernatant was assayed by UV–visible
spectrophotometer at a wavelength of 267 nm. All
the experiments were carried out in triplicate.
2.7. Swelling studies
The swelling behaviour of the chitosan and
CMC-g-PEA beads was studied in solutions of dif-
ferent pH at 37 "C. The beads were accurately
weighed (50 mg) (W0) and immersed in solutions
of pH 1.4 and 7.4. At predetermined time intervals
the swollen beads were weighed after they were
wiped with soft paper tissue (Wt). The degree of
swelling for each sample at time t was calculated
by using the expression: (Wt !W0)/W0 · 100, where
Wt andW0 are the weights of the beads at time t and
in the dry state, respectively.
2.8. Drug release studies
The release studies were performed in a glass
apparatus at 37 "C in HCl–KCl (pH 1.4) and phos-
phate buffer (pH 7.4) solutions. Drug loaded beads
(15 mg) were suspended in 100 ml of release medium
and stirred at 100 rpm in a horizontal laboratory
shaker and maintained at 37 "C in a water bath.
Samples (2 ml) were periodically removed, filtered
and assayed. The volume of each sample withdrawn
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was replaced by the same volume of fresh medium.
The amount of released ketoprofen was analyzed
with a spectrophotometer at 267 nm. The drug
release studies were performed in triplicate for each
of the samples.
3. Results and discussion
The water soluble carbodiimide, EDC, is a so-
called ‘zero-length’ crosslinker because the amide
linkages are formed without leaving a spacer mole-
cule. EDC reacts with carboxyl groups of CMC to
form an active ester intermediate. The intermediate
can react with a primary amine of PEA to form an
amide bond. Isourea is a by-product and can be eas-
ily removed by washing with water. The reaction
scheme for the preparation of CMC-g-PEA is given
in Fig. 1.
3.1. FT-IR and 1H NMR analysis
The FT-IR spectrum of chitosan (Fig. 2a) shows
a broad –OH stretch absorption band between 3450
and 3100 cm!1 and the aliphatic C–H stretch
between 2990 and 2850 cm!1. As the –OH stretch
band and the aliphatic C–H stretch band are
aligned, it appears as a broad band from 3450 and
2850 cm!1 in the spectrum. Other major absorption
band between 1220 and 1020 cm!1 represents the
free primary amino group (–NH2) at C2 position.
The peak at 1647 cm!1 represents acetylated amino
group of chitin, which indicates that the sample is
not fully deacetylated. The peak at 1384 cm!1 repre-
sents the –C–O stretch of primary alcoholic group
(—CH2–OH). In the IR spectrum of CMC
(Fig. 2b), the strong peaks at 1596 and 1411 cm!1
could be assigned to the respective asymmetry and
symmetry stretch vibration of COO!. Also, the C–




































Fig. 1. Reaction scheme for the preparation of CMC-g-PEA.














Fig. 2. FT-IR spectrum of (a) chitosan, (b) CMC and (c) CMC-
g-PEA.
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becomes stronger and moves to 1070 cm!1. The
results indicate that the carboxymethyl substitution
occurs at the C6 position of chitosan. In the IR spec-
trum of CMC-g-PEA (Fig. 2c), the absorption peak
at 1655 cm!1 can be assigned to the carbonyl stretch
of secondary amides (amide I band), at 1555 cm!1
to the N–H bending vibration of the amide II band.
In addition, peaks at 2850 and 2950 cm!1 were
ascribed to the aliphatic chain (–CH2). The absorp-
tion peak at 1730 cm!1 can be represented the C@O
stretch vibrations of carbonyl groups. Another
absorption peaks at 1160, 1082 and 1011 cm!1 can
be represented the stretch vibrations of P@O, P–
OH and P–O of phosphate group respectively.
Fig. 3 shows the 1H NMR spectra of CMC, PEA
and CMC-g-PEA. As shown in the spectrum of
Fig. 3. 1H NMR spectrum of (a) CMC, (b) PEA and (c) CMC-g-PEA.
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CMC (Fig. 3a), the chemical shifts at 4.5 ppm was
the protons of –CH2–COO
! at the C6 position of
the chitosan derivative (CMC). This indicated that
carboxymethyl substitute was observed on some of
the primary hydroxyl sites of the modified chitosan
structure. The spectrum of PEA (Fig. 3b) exhibited
peaks at 0.9 ppm due to the presence of methyl
groups, 1.24 ppm due to the presence of amine
group, 1.26 ppm due to the methylene groups, and
5.2–5.4 ppm due to the vinyl proton. The signal
around at 7.2 ppm is ascribed to CDCl3. Fig. 3c
shows the spectra of CMC-g-PEA copolymers.
The signals at 3.2–4.2 ppm are multiplet and those
are originated from CMC. The signals due to –
CH3, methylene and vinyl protons of PEA also
appeared in the spectrum of CMC-g-PEA copoly-
mer. Also, a new peak at 6.7 ppm was observed as
the amide group (–CONH–) was formed in the
CMC-g-PEA. These results clearly confirmed that
PEA has been successfully graft copolymerized into
CMC.
3.2. Properties of CMC-g-PEA beads
According to previous studies, drug release from
chitosan particles could be controlled by crosslink-
ing the matrix using chemical crosslinking agents
such as glutaraldehyde or ethylene glycol diglycidyl
ether [29,30]. However, these chemical crosslinking
agents have possibility of inducing undesirable
effects due its toxicity [31]. To overcome this disad-
vantage of chemical crosslinking, ionic-crosslinking
interaction has been proposed [32,33]. It is reported
that the beads prepared with TPP increased the
drug loading efficiency as well as prolonging the
drug release period [33]. TPP is non-toxic and mul-
tivalent anion. Therefore, in this study, CMC-g-
PEA beads were prepared by the ionic interaction
between a positively charged amino group of
CMC-g-PEA and a negatively charged counter ion
of TPP. The interaction could be controlled by
the charge density of TPP and CMC-g-PEA, which
is dependent on the pH value of solution [34]. In
original TPP solution (pH 8.6), TPP is dissociated





However in low pH, only P3O
5!
10 anions are present.
Moreover, CMC-g-PEA is a weak polybase, and as
pH of the solution decreases, the ionization of
amine group of CMC-g-PEA increases. Therefore,
one would expect that CMC-g-PEA beads prepared
in the original TPP solution can be dominated by
deprotonation and slightly ionic-crosslinking, but
CMC-g-PEA beads prepared in acidic TPP solution
can be dominated completely by ionic-crosslinking
[35,36]. Based on this fact, in this work, CMC-g-
PEA beads were prepared with TPP at pH 4. The
surface morphologies of control and drug loaded
CMC-g-PEA beads are shown in Fig. 4. The con-
trol CMC-g-PEA beads were about 800–1000 lm
in size and roughly spherical in shape, and appeared
to have smooth outer surfaces (Fig. 4a and b).
These beads were dense when compared to the
beads loaded with drug due to the higher crosslink-
ing density. Incorporation of drug into the beads
altered the surface morphology of CMC-g-PEA
beads. The results revealed that addition of drug
imparts a high degree of surface roughness to the
beads (Figs. 4c–f). With regard to the beads size,
it notably varied depending on the feed ratio: as
the feed ratio increased, the bead size increased
from 1000 to 1200 lm. Table 1 shows the effect of
feed ratio on loading efficiency. The feed ratio of
ketoprofen to CMC-g-PEA ranged from 0.5 to 1.
The results demonstrated that the loading efficiency
defined as the percentage of entrapped ketoprofen
to CMC-g-PEA is in the range of 68–82% and the
increase in feed ratio improves the loading content.
3.3. Swelling behaviour
The swelling behaviour of the chitosan and
CMC-g-PEA beads in acidic (pH 1.4) and basic
(pH 7.4) solutions at 37 "C is shown in Fig. 5. It is
evident that the character of swelling curves for
both chitosan and CMC-g-PEA beads changes sig-
nificantly over time in pH 1.4 compared to that in
pH 7.4. Moreover, the swelling can reach a stable
equilibrium more rapidly in pH 7.4 than in pH
1.4. The swelling behaviour of chitosan beads at
pH 1.4 was found to be preserved within 24 h, fol-
lowed by dissolution after 48 h. Generally, the swell-
ing process of the chitosan beads at a low pH
involves protonation of amino groups in the beads
[37,38]. Therefore, the repulsive force between the
positive charges of protonated amine groups of
chitosan molecules resulted in longer intermolecular
distances which would be responsible for higher
swelling degree and rapid disintegration of chitosan
particles. On the other hand, the observed swelling
rate of CMC-g-PEA beads is found to be slower
than that of control chitosan beads and also
CMC-g-PEA beads were found to maintain their
shape for 72 h and only after 72 h most of the beads
were dissolved in the medium. The slow swelling
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rate and high stability of CMC-g-PEA beads at pH
1.4 may be due to the complexity involved through
the inter/intra molecular bondings between the
grafted PEA side chains. The successful oral drug
carrier must be resistant to the impact of the pH
gradients due to pH changing from the strongly
acidic medium in the stomach to the weekly alkaline
medium in the intestine. Fig. 5a clearly showed that
CMC-g-PEA beads have higher stability than chito-
san beads at pH 1.4 and may be suitable for oral
and control drug delivery applications. The swelling
Fig. 4. SEM micrographs of (a) CMC-g-PEA beads and (b) its surface morphology, (c) beads loaded with drug (1:0.5 ratio) and (d) its
surface morphology, (e) beads loaded with drug (1:1) ratio and (f) its surface morphology.
Table 1













10 – – – 900
10 5 68 29 1100
10 10 82 69 1200
a Percentage of loaded ketoprofen, based on feed amount.
b Weight percentage of ketoprofen to CMC-g-PEA.
c Mean diameter.
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capability of CMC-g-PEA beads was found to be
similar to that of chitosan at pH 7.4 (Fig. 5b). How-
ever, CMC-g-PEA beads reached a stable equilib-
rium more rapidly (within 24 h) than chitosan
(within 48 h). The swelling degree of both chitosan
and CMC-g-PEA beads tends to decline after the
beads were swollen for some time, which may indi-
cate that the dissolution tendency of the beads
exceeds the swelling degree [39].
3.4. Drug release behaviour
The release of ketoprofen from CMC-g-PEA and
chitosan beads was carried out in acidic (pH 1.4)
and basic (pH 7.4) solutions at 37 "C. Figs. 6 shows
the release profiles of ketoprofen from CMC-g-PEA
and chitosan beads loaded with 29% and 69% of
drug as a function of time. The control chitosan
beads, which have less interaction with the drug
molecules, showed a faster release (t80% ' 7–12 h)
and rapidly disintegrated, whereas those based on
CMC-g-PEA remained intact in aqueous medium
and showed a slow and steady release (t80% ' 15–
30 h), being the equilibrium reached after 20 h. In
the CMC-g-PEA beads, the water-insoluble nature
of ketoprofen, ascribed to their hydrophobicity,
might govern the release pattern, accompanied with
physical interaction with CMC-g-PEA such as
hydrophobic interaction, hydrogen bonding, and
electrostatic interaction. In an aqueous solution,
micelles or self-aggregates can be formed by the
amphiphilic nature of the CMC-g-PEA due to their
intra and inter molecular hydrophobic interactions
[40]. The strong interaction of the hydrophobic
cores of micelles or self-aggregates with the hydro-
phobic drug molecules could be a responsible for
the slow release of drug from CMC-g-PEA beads.
Here, the hydrophobic core serves as a reservoir
for hydrophobic drug molecules, whereas the
hydrophilic shell affects their pharmacokinetic
behaviour. In addition, the slow release may also
be attributed to a hydrophobic barrier limiting















































Fig. 5. Swelling behaviour of CMC-g-PEA and Chitosan beads
at (a) pH 1.4 and (b) 7.4.
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Fig. 6. Release of ketoprofen from (a) 29% and (b) 69% drug
loaded chitosan and CMC-g-PEA beads.
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access of water and dissolution of the drug. The
amount and percentage of drug released from both
the CMC-g-PEA and chitosan beads was pH-depen-
dent and occurs at higher rate in acidic medium
than in basic medium. This can be explained consid-
ering the rate of diffusion from the swollen beads in
acidic and basic media. In basic medium (pH 7.4),
there is a limited swelling of the beads which inhibits
the diffusion of drugs at a faster rate as it occurs in
acidic medium (pH 1.4). Initially, the magnitude of
swelling of beads in acidic medium is very high and
gives rise to a significant burst effect through uncon-
trolled diffusion, but becomes almost constant due
to controlled diffusion at beads equilibrium swell-
ing. In the acidic medium, the rate of drug release
from chitosan beads was found to be higher than
that of CMC-g-PEA beads. A higher swelling of
the chitosan beads due to their longer intermolecu-
lar distances caused by the repulsive force between
the protonated amine groups at the acidic medium
enhances the diffusion of the drugs at a faster rate.
But in the case of CMC-g-PEA beads, the drug
release would be decreased due to the hydrophobic
interaction of drug with CMC-g-PEA as mentioned
before.
The release profile of the highly drug loaded
beads (Fig. 6b) has been found to be similar to that
of the beads, loaded with lower amounts of the drug
(Fig. 6a). In both cases, an initial burst release fol-
lowed by a slow release of ketoprofen occurred.
The results have shown that the percentage of drug
released from CMC-g-PEA beads has decreased
with the increase in concentration of ketoprofen.
However, as expected, the total amount of drug
released was found to be higher from the highly
loaded beads in comparison to the beads loaded
with low concentrations. The kinetics of drug
release by CMC-g-PEA beads was dependent on
the initial drug loading. For beads with 29% of
drug, the duration of release was up to 45 h. For
69% drug loads, the duration of release increased
to 50 h. The explanation of this phenomenon may
reside with the drug solubility, particularly in the
case of hydrophobic drugs that alter the hydropho-
bic/hydrophilic character of the system [23]. At high
drug loading (69%), there is a reduced level of
hydration that would give rise to a slow release of
the drug.
According to Peppas [41,42], there are three pri-
mary mechanisms by which the release of active
agents can be controlled: erosion, diffusion, and
swelling followed by diffusion. Erosion may take
place via hydration or hydrolysis of the bulk, the
polymer being slowly degraded starting at the
periphery of the particle. Diffusion can occur
through the unhydrated polymer matrix but will
generally be facilitated as the polymer gradually
swells in contact with the body fluids. In the case
of CMC-g-PEA beads, it was observed that drug
release is quite fast at the initial period of time.
About 40–60% of the drug is released in about
10 h. Then, almost a constant and much slower
release rate is observed. Notice that the swelling
curves are quite similar to the release curves. It
seems that release obeys a swelling-controlled
release mechanism, especially at this initial period
of release. After this initial period, in which the
swelling equilibrium is achieved, the release is most
probably followed by a diffusion-controlled mecha-
nism. This is an expected behaviour found in the
case of hydrogels during drug release studies; first
a hydration followed by polymer chain relaxation
takes place by water penetration into the matrix.
During this process, high release rates occur due
to the presence of the drug at and near the surface.
After forming the gel structure the release contin-
ues with the diffusion mechanism through the
matrix by a much slower release rate. This typical
phenomenon is the same in the case of drug release
from CMC-g-PEA beads. However, there is
another controlling parameter for the drug release
profile, conferred by the ionic nature of the cross-
linking present in between the polymer chains. The
disruption of such linkage may accelerate the
release kinetic especially in the later stages that
may help for maintaining a more stable delivery
of the drug with time. Note that this process could
be controlled by changing the concentration of
crosslinking agent.
4. Conclusions
Chemically modified chitosans have potential to
be used in controlled drug delivery system. In this
work, CMC was hydrophobically modified by graft-
ing with PEA in order to produce a system contain-
ing amphiphilic capability. Due to this character,
CMC-g-PEA can be used as matrices for the con-
trolled delivery of hydrophobic drugs. The grafting
reaction was confirmed by FT-IR spectroscopy and
1H NMR. For the release study, the CMC-g-PEA
beads were prepared by an ionic gelation method.
The CMC-g-PEA beads show a pH-dependent
swelling behaviour, which makes them appropriate
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for pH-responsive delivery of drugs. The prelimin-
ary results for ketoprofen as a model drug, includ-
ing loading and release experiments, indicate that
this system seems to be a very promising vehicle
for the administration of controlled release of
hydrophobic drugs with a pH-responsive capability.
The strong hydrophobic interaction of CMC-g-PEA
with the drug molecules could be a main reason for
the slow and steady release of the drug from CMC-
g-PEA beads. It is believed that the release of drug
may be controlled by swelling followed by diffusion-
controlled mechanism.
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